Search hospitals > Washington > Renton
Valley Medical Center
Claim this profileRenton, Washington 98055
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
Conducts research for Non-Small Cell Lung Cancer
161 reported clinical trials
4 medical researchers
Summary
Valley Medical Center is a medical facility located in Renton, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Non-Small Cell Lung Cancer and other specialties. Valley Medical Center is involved with conducting 161 clinical trials across 348 conditions. There are 4 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, John A. Keech, and Richard Wall, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
148 reported clinical trials
226 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Tumors
Expert in Leukemia
52 reported clinical trials
109 drugs studied
John A. KeechMultiCare Auburn Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
3 reported clinical trials
12 drugs studied
Richard Wall, MDValley Medical Center5 years of reported clinical research
Studies Traumatic Brain Injury
Studies Stroke
1 reported clinical trial
1 drug studied
Clinical Trials running at Valley Medical Center
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Gastric Cancer
Renal Cell Carcinoma
Tumors
Esophageal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Valley Medical Center?
Valley Medical Center is a medical facility located in Renton, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Non-Small Cell Lung Cancer and other specialties. Valley Medical Center is involved with conducting 161 clinical trials across 348 conditions. There are 4 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, John A. Keech, and Richard Wall, MD.